Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb Three-arm, Two-stage HIV Prophylactic Vaccine Trial With a Second Randomisation to Compare TAF/FTC to TDF/FTC as Pre-exposure Prophylaxis

NCT04066881 is registered in ClinicalTrials.gov with MRC/UVRI and LSHTM Uganda Research Unit as lead sponsor.

NCT NCT04066881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04066881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb Three-arm, Two-stage HIV Prophylactic Vaccine Trial With a Second Randomisation to Compare TAF/FTC to TDF/FTC as Pre-exposure Prophylaxis
Lead sponsor
MRC/UVRI and LSHTM Uganda Research Unit
Phase
Phase 2
Overall status
Completed
Start date
December 15, 2020
Completion date
December 31, 2024
Enrollment
1,512 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections